Zobrazeno 1 - 10
of 438
pro vyhledávání: '"M. N. Stein"'
Autor:
Hongxia Lin, Ah-Ng Tony Kong, Murugesan Gounder, M. N. Stein, Joseph R. Bertino, Robert S. DiPaola
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 66:371-375
R-(-)-gossypol acetic acid (AT-101), a natural BH3 mimetic, is investigated in a Phase I/II clinical trial for the treatment of advanced solid tumor malignancies. Gossypol undergoes rapid degradation in solution phase, which causes major technical di
Autor:
Ahamed Saleem, Eileen White, Urmila Santanam, Dmitri Dvorzhinski, Kevin Bray, M. N. Stein, Robert S. DiPaola, Robin Mathew
Publikováno v:
The Prostate. 72:1374-1381
PURPOSE Targeting multiple anti-apoptotic proteins is now possible with the small molecule BH3 domain mimetics such as ABT-737. Given recent studies demonstrating that autophagy is a resistance mechanism to multiple therapeutic agents in the setting
Autor:
Murugesan Gounder, Susan Goodin, Ah-Ng Tony Kong, Robert S. DiPaola, Joseph R. Bertino, M. N. Stein, Hongxia Lin
Publikováno v:
Biomedical Chromatography. 26:650-654
2-Deoxyglucose (2-DG), an analog of glucose, is widely used to interfere with glycolysis in tumor cells and studied as a therapeutic approach in clinical trials. To evaluate the pharmacokinetics of 2-DG, we describe the development and validation of
Autor:
Eileen White, Murugesan Gounder, Robert S. DiPaola, Hongxia Lin, Simantini Eddy, Susan Goodin, Kevin Bray, M. N. Stein, Chandrika Jeyamohan, Dmitri Dvorzhinski
Publikováno v:
The Prostate. 70:1388-1394
A profound difference between cancer and normal tissues is the preferential utilization of glycolysis by cancer cells. To translate this paradigm in the clinic, we completed a phase I study of 2-deoxyglucose (2DG), and assessed 2DG uptake with fluoro
Autor:
David J. Foran, Cristina M. Karp, Dmitri Dvorzhinski, Anu Thalasila, Eileen White, Kevin Bray, Robin Mathew, M. N. Stein, Robert S. DiPaola, V. P. S. Garikapaty, Donyell Doram, Brian Beaudoin, Michael May
Publikováno v:
The Prostate. 68:1743-1752
BACKGROUND Autophagy is a starvation induced cellular process of self-digestion that allows cells to degrade cytoplasmic contents. The understanding of autophagy, as either a mechanism of resistance to therapies that induce metabolic stress, or as a
Autor:
Katz, Dana1,2 (AUTHOR) dana.katz@ppk.elte.hu, Horváth, Zsolt2,3 (AUTHOR), Pontes, Halley M.4 (AUTHOR), Koncz, Patrik1,2 (AUTHOR), Demetrovics, Zsolt2,3,5 (AUTHOR), Király, Orsolya2,3 (AUTHOR)
Publikováno v:
Journal of Behavioral Addictions. Sep2024, Vol. 13 Issue 3, p716-728. 13p.
Autor:
Jupowicz-Ginalska, Anna1 a.ginalska@uw.edu.pl, Kopecka-Piech, Katarzyna2 katarzyna.kopecka-piech@umcs.pl
Publikováno v:
Observatorio (OBS*). 2024, Vol. 18 Issue 3, p75-95. 21p.
Autor:
M. N. Stein, Stephen B Cantrell
Publikováno v:
Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 57(6)
Autor:
DURSUN, Asiye1
Publikováno v:
AYNA Clinical Psychology Journal. 2024, Vol. 11 Issue 2, p448-465. 18p.
Autor:
James J. Chen, Jing Fan, Eileen White, Kevin Bray, M. N. Stein, Alexandria Lau, Anahita Ghavami, Donna D. Zhang, Joshua D. Rabinowitz, Robin Mathew, Jurre J. Kamphorst, Hsin-Yi Chen, Robert S. DiPaola
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e41831 (2012)
PLoS ONE, Vol 7, Iss 7, p e41831 (2012)
mTOR inhibitors are used clinically to treat renal cancer but are not curative. Here we show that autophagy is a resistance mechanism of human renal cell carcinoma (RCC) cell lines to mTOR inhibitors. RCC cell lines have high basal autophagy that is